HS-001

· Heartseed Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS-001, covering 2025-09-22 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study) [Phase 1, Phase 2]

See pricing